Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Cited by (1,003)

Items 301–400 of 1,003

1. Death Receptors in Cutaneous Biology and Disease
   Philippe Wehrli, I. Viard, Roberto R. Bullani, Lars Einar French, Jürg Tschopp · 2000 · Journal of Investigative Dermatology
2. Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms
   Kazuhiro Ishiguro, Takafumi Ando, Osamu Maeda, Naoki Ohmiya, Yasumasa Niwa, Kenji Kadomatsu, Hidemi Goto · 2007 · Biochemical and Biophysical Research Communications
3. Transcription Factor NF-κB Differentially Regulates Death Receptor 5 Expression Involving Histone Deacetylase 1
   Shashirekha Shetty, Bonnie A. Graham, Jennifer G. Brown, Xiaojie Hu, Nicolette Vegh-Yarema, Gary A. Harding, James T. Paul, Spencer Bruce Gibson · 2005 · Molecular and Cellular Biology
4. An Lnc RNA (GAS5)/SnoRNA-derived piRNA induces activation of TRAIL gene by site-specifically recruiting MLL/COMPASS-like complexes
   Xin He, Xinxin Chen, Xue Zhang, Xiaobing Duan, Ting Shuang Pan, Qifei Hu, Yijun Zhang, Fudi Zhong, Jun Liu, Hong Zhang et al. · 2015 · Nucleic Acids Research
5. TRAIL of Hope Meeting Resistance in Cancer
   David Deng, Khalid Shah · 2020 · Trends in cancer
6. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice
   Makoto Ochi, Hideki Ohdan, Hiroshi Mitsuta, Takashi Onoe, Daisuke Tokita, Hidetaka Hara, Kohei Ishiyama, Wendy Zhou, Yuka Tanaka, Toshimasa Asahara · 2004 · Hepatology
7. Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies
   Éric Solary, Nathalie M Droin, Ali Bettaı̈eb, Laurent Corcos, Marie‐Thérèse Dimanche‐Boitrel, Carmen Garrido · 2000 · Leukemia
8. Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling
   Wafik S. El‐Deiry · 2001 · Cell Death and Differentiation
9. Implication of TNF-Related Apoptosis-Inducing Ligand in Inflammatory Intestinal Epithelial Lesions
   Bernadette Bègue, Harald Wajant, Jean–Christophe Bambou, Laurent Dubuquoy, Daniela Siegmund, Jean‐François Beaulieu, Danielle Canioni, Dominique D. Berrebi, Nicole Brousse, Pierre Desreumaux et al. · 2006 · Gastroenterology
10. Evidence that the death receptor DR4 is a DNA damage‐inducible, p53‐regulated gene
    Baoxiang Guan, Ping Yue, Gary L. Clayman, Shi‐Yong Sun · 2001 · Journal of Cellular Physiology
11. Crystal Structure of TRAIL-DR5 Complex Identifies a Critical Role of the Unique Frame Insertion in Conferring Recognition Specificity
    Sun‐Shin Cha, Byungje Sung, Young‐A Kim, Young-Lan Song, Hyun-Ju Kim, Sunshin Kim, Myung‐Shik Lee, Byung‐Ha Oh · 2000 · Journal of Biological Chemistry
12. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
    Nesrin Özören, Kunhong Kim, Timothy Francis Burns, David T. Dicker, Albert D. Moscioni, Wafik S. El‐Deiry · 2000 · PubMed
13. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis
    Claus Belka, Justine Rudner, Sebastian Wesselborg, Anna Stępczyńska, Patrizia Marini, A. Lepple-Wienhues, Heidrun Faltin, MAXIMILIAN BAMBERG, Wilfried Budach, Klaus Schulze‐Osthoff · 2000 · Oncogene
14. Towards novel paradigms for cancer therapy
    Valeria Pavet, Maximiliano M. Portal, Jean-Francois Moulin, Raoul Herbrecht, Hinrich Gronemeyer · 2010 · Oncogene
15. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo
    Khalid Shah, Yi Tang, Xandra O. Breakefield, Ralph Weissleder · 2003 · Oncogene
16. Tumor therapeutics by design: targeting and activation of death receptors
    Harald Wajant, Jeannette Gerspach, Klaus Pfizenmaier · 2005 · Cytokine & Growth Factor Reviews
17. Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
    Hiroya Taniguchi, Tatsushi Yoshida, Mano Horinaka, Takashi Yasuda, Ahmed E. Goda, Masako Konishi, Miki Wakada, Keisho Kataoka, Toshikazu Yoshikawa, Toshiyuki Sakai · 2008 · Cancer Research
18. FLIP and the death effector domain family
    J W Yu, Yigong Shi · 2008 · Oncogene
19. TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
    Christian T. Hellwig, Markus Rehm · 2012 · Molecular Cancer Therapeutics
20. Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells
    Jan D. Lünemann, Sonia Waiczies, Stefan Ehrlich, Uwe Wendling, Bibiane Seeger, Thomas Kamradt, Frauke Zipp · 2002 · The Journal of Immunology
21. Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter.
    Jörn Sträter, Ulf Hinz, Henning Walczak, Gunhild Mechtersheimer, Karin Koretz, Christian H. Herfarth, Peter Möller, Thomas Lehnert · 2002 · PubMed
22. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
    Karthikeyan Kandasamy, Rakesh K. Srivastava · 2002 · PubMed
23. Curcumin sensitizes prostate cancer cells to tumor necrosis factor–related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-κB through suppression of IκBα phosphorylation
    Dorrah Deeb, Hao Jiang, Xiaohua Gao, Mikehl S. Hafner, Henry Wong, George Divine, Robert Chapman, Scott A. Dulchavsky, Subhash C. Gautam · 2004 · Molecular Cancer Therapeutics
24. Is TRAIL the holy grail of cancer therapy?
    Thomas E. Newsom-Davis, Silvia Prieske, Henning Walczak · 2009 · APOPTOSIS
25. A new dawn for the use of traditional Chinese medicine in cancer therapy
    Harendra S. Parekh, Gang Liu, Ming Qian Wei · 2009 · Molecular Cancer
26. Untitled work
    2001 · PubMed
27. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
    Carmen Ruiz‐Ruiz, Cristina Muñoz‐Pinedo, Abelardo López‐Rivas · 2000 · PubMed
28. p53-Independent Upregulation of KILLER/DR5 TRAIL Receptor Expression by Glucocorticoids and Interferon-γ
    Raymond D. Meng, Wafik S. El‐Deiry · 2001 · Experimental Cell Research
29. Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
    Pascal Schneider, Dian L. Olson, Aubry Tardivel, Beth Browning, Alexey A. Lugovskoy, Dahai Gong, Max Dobles, Sylvie Hertig, Kay Hofmann, Herman van Vlijmen et al. · 2003 · Journal of Biological Chemistry
30. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis
    Yoichi Mizutani, Hiroyuki Nakanishi, Yong Zhong Li, Hiroki Matsubara, Kosuke Yamamoto, Nodoka Sato, Takumi Shiraishi, Terukazu Nakamura, Kazuya Mikami, Koji Okihara et al. · 2007 · International Journal of Oncology
31. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosis
    Evdokiou, Andreas, Bouralexis, Stelios, Atkins, Gerald J., Chai, Fugui, Hay, Shelley, Clayer, Mark, Findlay, David M. · 2002 · International Journal of Cancer
32. The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology
    Giorgio Zauli, Paola Secchiero · 2006 · Cytokine & Growth Factor Reviews
33. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand
    Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Toshiyuki Sakai · 2006 · Molecular Cancer Therapeutics
34. Apoptosis-modulating agents in combination with radiotherapy—current status and outlook
    Claus Belka, Verena Jendrossek, Martin N. Pruschy, Stefan R. Vink, Marcel Verheij, Wilfried Budach · 2004 · International Journal of Radiation Oncology*Biology*Physics
35. Ursolic Acid, a Pentacyclin Triterpene, Potentiates TRAIL-induced Apoptosis through p53-independent Up-regulation of Death Receptors
    Sahdeo Prasad, Vivek Ramshankar Yadav, Ramaswamy Kannappan, Bharat Bhushan Aggarwal · 2010 · Journal of Biological Chemistry · Retracted
36. Apoptosis Initiation Through the Cell-Extrinsic Pathway
    Pradeep M. Nair, Min Lu, Sean Petersen, Avi Ashkenazi · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
37. All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity
    Ariel Ramírez-Labrada, Cecilia Pesini, Llipsy Santiago, Sandra Hidalgo, Adanays Calvo-Pérez, Carmen Oñate, Alejandro Andrés-Tovar, Marcela Garzón-Tituaña, Iratxe Uranga-Murillo, Maykel A. Arias et al. · 2022 · Frontiers in Immunology
38. Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
    Felicitas Merz, Frank Gaunitz, Faramarz Dehghani, Christof Renner, Jürgen Meixensberger, Angelika Gutenberg, Alf Giese, Kosta Schopow, Christian T. Hellwig, Michael Schäfer et al. · 2013 · Neuro-Oncology
39. Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back
    Lenka Koklesová, Alena Líšková, Marek Samec, Constanze Buhrmann, Samson Mathews Samuel, Elizabeth Varghese, Milad Ashrafizadeh, Masoud Najafi, Mehdi Shakibaei, Dietrich Büsselberg et al. · 2020 · Cancers
40. Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL‐R2 gene 1
    Tatsushi Yoshida, Ayaka Maeda, Naoki Tani, Toshiyuki Sakai · 2001 · FEBS Letters
41. TRAIL regulates normal erythroid maturation through an ERK-dependent pathway
    Paola Secchiero, Elisabetta Melloni, Markku Heikinheimo, Susanna Mannisto, Roberta Di Pietro, Antonio Iacone, Giorgio Zauli · 2003 · Blood
42. Emerging non‐apoptotic functions of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)/Apo2L
    Roberta Di Pietro, Giorgio Zauli · 2004 · Journal of Cellular Physiology
43. Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents.
    Kimberly A. Candido, K Shimizu, Julie C. McLaughlin, Robin Kunkel, Jennifer A. Fuller, Bruce G. Redman, Elaine K. Thomas, Brian J. Nickoloff, James J. Mulé · 2001 · PubMed
44. Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study
    Stephen Leong, Roger B. Cohen, Daniel L. Gustafson, Corey Jay Langer, D. Ross Camidge, Kristin Padavic, Lia Gore, Margaret Smith, Laura Q.M. Chow, Margaret von Mehren et al. · 2009 · Journal of Clinical Oncology
45. Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
    Christian Sordo‐Bahamonde, Seila Lorenzo‐Herrero, Ángel Ramírez Páyer, Segundo R. Gonzalez, Alejandro López‐Soto · 2020 · International Journal of Molecular Sciences
46. TRAIL receptor–mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality
    Corazza, Nadia, Jakob, Sabine, Schaer, Corinne, Frese, Steffen, Keogh, Adrian, Stroka, Deborah, Kassahn, Daniela, Torgler, Ralph, Mueller, Christoph, Schneider, Pascal et al. · 2006 · Journal of Clinical Investigation
47. Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
    Johannes Lemke, Silvia von Karstedt, Muad Y Abd El Hay, Annalisa Conti, Frederick Arce Vargas, Antonella Montinaro, Kerstin Papenfuss, Mona A El-Bahrawy, Henning Walczak · 2013 · Cell Death and Differentiation
48. Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease
    Markus Weckmann, Adam Collison, Jodie Louise Simpson, Matthias Kopp, Peter A. B. Wark, Mark John Smyth, Hideo Yagita∥, KLAUS INGO MATTHAEI, Nicole G. Hansbro, Bruce Whitehead et al. · 2007 · Nature Medicine
49. TRAIL: a multifunctional cytokine
    Uta Schaefer · 2007 · Frontiers in bioscience
50. Expression of tumor necrosis factor–related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis
    Dae Young Zang, Ray G. Goodwin, Michael R. Loken, Eileen M. Bryant, H. Joachim Deeg · 2001 · Blood
51. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL
    Claus Belka, B Schmid, Patrizia Marini, Elise Durand, Justine Rudner, Heidrun Faltin, MAXIMILIAN BAMBERG, Klaus Schulze‐Osthoff, Wilfried Budach · 2001 · Oncogene
52. TRAILing death in cancer
    Grégory Mellier, Sinong Huang, Kirthan Shenoy, Shazib Pervaiz · 2009 · Molecular Aspects of Medicine
53. Crosstalk between Apoptosis and Autophagy: Molecular Mechanisms and Therapeutic Strategies in Cancer
    Abdelouahid El‐Khattouti, Denis Selimović, Youssef Haïkel, Mohamed Hassan · 2013 · Journal of Cell Death
54. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design
    Marek Łoś, Christof J Burek, Christopher Stroh, Konrad Benedyk, Hubert Hug, Andrzej Adam Mackiewicz · 2003 · Drug Discovery Today
55. TRAIL Causes Cleavage of Bid by Caspase-8 and Loss of Mitochondrial Membrane Potential Resulting in Apoptosis in BJAB Cells
    Hiroyuki Yamada, Saeko Tada‐Oikawa, Atsumasa Uchida, Shosuke Kawanishi · 1999 · Biochemical and Biophysical Research Communications
56. The TRAIL Decoy Receptor TRUNDD (DcR2, TRAIL-R4) Is Induced by Adenovirus-p53 Overexpression and Can Delay TRAIL-, p53-, and KILLER/DR5-Dependent Colon Cancer Apoptosis
    Raymond D. Meng, E. Robert McDonald, M. Saeed Sheikh, Albert J. Fornace, Wafik S. El‐Deiry · 2000 · Molecular Therapy
57. A Tumor-Targeted and Conditionally Replicating Oncolytic Adenovirus Vector Expressing TRAIL for Treatment of Liver Metastases
    Pavel Sova, Xiao-Wei Ren, Shaoheng Ni, Kathrin Maria Bernt, Jie Mi, Nancy Kiviat, André Lieber · 2004 · Molecular Therapy
58. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.
    Bendi Gong, Alexandru Almasan · 2000 · PubMed
59. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Ian F. Pollack, Melanie Erff, Avi Ashkenazi · 2001 · PubMed
60. Rel/NF-κB Transcription Factors Protect against Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Up-regulating the TRAIL Decoy Receptor DcR1
    David Bernard, Brigitte Quatannens, Bernard Vandenbunder, Corinne Abbadie · 2001 · Journal of Biological Chemistry
61. Death to the bad guys: Targeting cancer via Apo2L/TRAIL
    Stelios Bouralexis, David M. Findlay, Andreas Evdokiou · 2005 · APOPTOSIS
62. Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells
    Sandrine Lacour, Olivier Micheau, Arlette Hammann, Véronique Drouineaud, Jürg Tschopp, Éric Solary, Marie‐Thérèse Dimanche‐Boitrel · 2003 · Oncogene
63. Overexpression of Soluble TRAIL Induces Apoptosis in Human Lung Adenocarcinoma and Inhibits Growth of Tumor Xenografts in Nude Mice
    Juan Shi, Dexian Zheng, Yanxin Liu, Mai Har Sham, Paul K.H. Tam, Farzin Farzaneh, Ruian Xu · 2005 · Cancer Research
64. Tissue Inhibitor of Metalloproteinase-1 Protects Human Breast Epithelial Cells from Extrinsic Cell Death: A Potential Oncogenic Activity of Tissue Inhibitor of Metalloproteinase-1
    Xu-Wen Liu, Marcus E. Taube, Kikyung Jung, Zhong Dong, Yong Jun Lee, Stefanie Roshy, Bonnie F. Sloane, Rafael A. Fridman, Hyeong-Reh Choi Kim · 2005 · Cancer Research
65. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
    Lingyue Gao, Zhuo‐Xun Wu, Yehuda G. Assaraf, Zhe‐Sheng Chen, Lihui Wang · 2021 · Drug Resistance Updates
66. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1)
    Zuliani, C, Kleber, S, Klussmann, S, Wenger, T, Kenzelmann, M, Schreglmann, N, Martinez, A, del Rio, J A, Soriano, E, Vodrazka, P et al. · 2006 · Cell Death & Differentiation
67. Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation
    Masaya Shigeno, Kazuhiko Nakao, Tatsuki Ichikawa, Kasumi Suzuki, Atsushi Kawakami, Seigou Abiru, Seiji Miyazoe, Yuichi Nakagawa, Hiroki Ishikawa, Keisuke Hamasaki et al. · 2003 · Oncogene
68. Apoptosis and drug response
    Janet A. Houghton · 1999 · Current Opinion in Oncology
69. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2
    Anupama Munshi, Gus Pappas, Tsuyoshi Honda, Timothy J. McDonnell, Anas Younes, Yang Li, Raymond E. Meyn · 2001 · Oncogene
70. Tunicamycin Sensitizes Human Melanoma Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis by Up-regulation of TRAIL-R2 via the Unfolded Protein Response
    Chen Chen Jiang, Li Hua Chen, Susan K. H. Gillespie, Kelly A. Avery‐Kiejda, Nizar Mahmoud Mhaidat, Yu Fang Wang, Rick Francis Thorne, Xu Dong Zhang, Peter Hersey · 2007 · Cancer Research
71. The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer
    Julio M. Pimentel, Junying Zhou, Gen Sheng Wu · 2023 · Cancers
72. Upregulation of FLIPSby Akt, a possible inhibition mechanism of TRAIL‐induced apoptosis in human gastric cancers
    Seon Young Nam, Gyung‐Ah Jung, Gwong‐Cheung Hur, Hee Yong Chung, Won–Ho Kim, Dai‐Wu Seol, Byung Lan Lee · 2003 · Cancer Science
73. The linear ubiquitin chain assembly complex regulates TRAIL‐induced gene activation and cell death
    Lafont, Elodie, Kantari‐Mimoun, Chahrazade, Draber, Peter, De Miguel, Diego, Hartwig, Torsten, Reichert, Matthias, Kupka, Sebastian, Shimizu, Yutaka, Taraborrelli, Lucia, Spit, Maureen et al. · 2017 · The EMBO Journal
74. The multifaceted role of TRAIL signaling in cancer and immunity
    Ludmila Cardoso Alves, Nadia Corazza, Olivier Micheau, Philippe Krebs · 2020 · FEBS Journal
75. The biological role of the Fas/FasL system during tumor formation and progression
    Ernst Reichmann A · 2002 · Seminars in Cancer Biology
76. TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window
    Ronald Koschny, Tom M. Ganten, Jaromir Sykora, Tobias L. Haas, Martin Ronald Sprick, Armin Kolb, Wolfgang Stremmel, Henning Walczak · 2007 · Hepatology
77. Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo
    Patrizia Marini, S. Denzinger, D Schiller, S Kauder, Stefan Welz, Robin C. Humphreys, Peter T. Daniel, Verena Jendrossek, Wilfried Budach, Claus Belka · 2006 · Oncogene
78. Selective Inhibition of FLICE-like Inhibitory Protein (FLIP) Expression With Small Interfering RNA Oligonucleotides (siRNAs) Is Sufficient to Sensitize Tumor Cells for TRAIL-Induced Apoptosis
    Daniela Siegmund, Philipp Hadwiger, Klaus Pfizenmaier, Hans‐Peter Vornlocher, Harald Wajant · 2002 · Molecular Medicine
79. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Dai‐Wu Seol, Jianrong Li, M H Seol, Sang‐Youel Park, Robert V. Talanian, Timothy R. Billiar · 2001 · PubMed
80. APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fcγ Receptors
    Christian Gieffers, Michael Kluge, Christian Merz, Jaromir Sykora, Meinolf Thiemann, René Schaal, Carmen Fischer, Marcus Branschädel, Behnaz Ahangarian Abhari, Peter Hohenberger et al. · 2013 · Molecular Cancer Therapeutics
81. Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer Therapy
    Anas Younes, Marshall E. Kadin · 2003 · Journal of Clinical Oncology
82. Death squads enlisted by the tumour suppressor p53
    Ewa Malgorzata Michalak, Andreas Villunger, Miriam Erlacher, Andreas Strasser · 2005 · Biochemical and Biophysical Research Communications
83. Curcumin [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1–6-heptadine-3,5-dione; C21H20O6] Sensitizes Human Prostate Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand/Apo2L-Induced Apoptosis by Suppressing Nuclear Factor-κB via Inhibition of the Prosurvival Akt Signaling Pathway
    Dorrah Deeb, Hao Jiang, Xiaohua Gao, Shaza N. Al‐Holou, Andrew L. Danyluk, Scott A. Dulchavsky, Subhash C. Gautam · 2007 · Journal of Pharmacology and Experimental Therapeutics
84. Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) Sequentially Upregulates Nitric Oxide and Prostanoid Production in Primary Human Endothelial Cells
    Giorgio Zauli, Assunta Pandolfi, Arianna Gonelli, Roberta Di Pietro, Simone Guarnieri, Giovanni Ciabattoni, Rosalba Rana, Marco Vitale, Paola Secchiero · 2003 · Circulation Research
85. Molecular mechanisms of cisplatin resistance in bladder cancer
    Ross M. Drayton, James W.F. Catto · 2012 · Expert Review of Anticancer Therapy
86. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
    G. Zauli, E. Rimondi, V. Nicolin, E. Melloni, C. Celeghini, P. Secchiero · 2004 · Blood
87. Disruption of NF-κB Signaling Reveals a Novel Role for NF-κB in the Regulation of TNF-Related Apoptosis-Inducing Ligand Expression
    Tudor M. Baetu, Hakju Kwon, Sonia Sharma, Nathalie Grandvaux, John B. Hiscott · 2001 · The Journal of Immunology
88. Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer
    Perry To‐Tien Yin, Shreyas Shah, Nicholas J. Pasquale, Olga B. Garbuzenko, Tamara Minko, Ki‐Bum Lee · 2015 · Biomaterials
89. CD99 Signals Caspase-Independent T Cell Death
    Rolf Dagfinn Pettersen, Ghislaine Bernard, Mette Kløvstad Olafsen, Monique Pourtein, Sverre Olaf Lie · 2001 · The Journal of Immunology
90. Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
    Valeria Pavet, Julien Beyrath, Christophe Pardin, Alexandre Morizot, Marie‐Charlotte Lechner, Jean‐Paul Briand, Miriam Wendland, Wolfgang Maison, Sylvie Fournel, Olivier Micheau et al. · 2010 · Cancer Research
91. Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells
    Qin He, Ying Kao Huang, M. Saeed Sheikh · 2003 · Oncogene
92. BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
    Gustavo Pessini Amarante-Mendes, Aamir Rana, Tarcila Santos Datoguia, Nelson Hamerschlak, Gabriela Brumatti · 2022 · Pharmaceutics
93. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
    Erika M. Gibson, Elizabeth S. Henson, Neil Haney, Jacylyn Villanueva, Spencer Bruce Gibson · 2002 · PubMed
94. Downregulation of Smac/DIABLO Expression in Renal Cell Carcinoma and Its Prognostic Significance
    Yoichi Mizutani, Hiroyuki Nakanishi, Kosuke Yamamoto, Yong Nan Li, Hiroki Matsubara, Kazuya Mikami, Koji Okihara, Akihiro Kawauchi, Benjamin Bonavida, Tsuneharu Miki · 2004 · Journal of Clinical Oncology
95. Overcoming apoptosis deficiency of melanoma—Hope for new therapeutic approaches
    Jürgen Eberle, Bahtier M. Kurbanov, Amir M. Hossini, Uwe Trefzer, Lothar F. Fecker · 2007 · Drug Resistance Updates
96. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand
    Takeshi Ken Miyamoto, Fumio Arai, Osamu Ohneda, Katsumasa Takagi, Dirk M. Anderson, Toshio Suda · 2000 · Blood
97. Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation
    Martin Leverkus, Martin Ronald Sprick, Tina Wachter, Thilo Mengling, Bernd Baumann, Edgar Serfling, Eva-B. Brücker, Matthias Goebeler, Manfred Neumann, Henning Walczak · 2003 · Molecular and Cellular Biology
98. TNF-Related Apoptosis-Inducing Ligand-Induced Apoptosis of Melanoma Is Associated with Changes in Mitochondrial Membrane Potential and Perinuclear Clustering of Mitochondria
    Wayne D. Thomas, Xu Dong Zhang, Agustin V. Franco, Tam Thuan Nguyen, Peter Hersey · 2000 · The Journal of Immunology
99. Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
    Magdalena M. Gerlach, Felicitas Merz, Gunnar Wichmann, Christoph Kubick, Christian Wittekind, Florian Lordick, Andreas Dietz, Ingo Bechmann · 2013 · British Journal of Cancer
100. Staurosporine Induces Necroptotic Cell Death under Caspase-Compromised Conditions in U937 Cells
     Zsuzsanna A. Dunai, Gergely Imre, Gábor Barna, Tamás Korcsmáros, István Peták, Pál I. Bauer, Rudolf Mihalik · 2012 · PLoS ONE